Clinical trial
Study of Treatment of Antiretroviral-naive, HIV-1-Infected Patients Comparing…
NCT00158821 · Gilead Sciences, Industry · Completed
Key facts
| NCT number | NCT00158821 |
|---|---|
| Title | Study of Treatment of Antiretroviral-naive, HIV-1-Infected Patients Comparing Tenofovir Disoproxil Fumarate Administered in Combination With Lamivudine and Efavirenz vs. Stavudine, Lamivudine and Efavirenz. |
| Official title | A Phase 3, Randomized, Double-Blind, Multicenter Study of the Treatment of Antiretroviral-naive, HIV-1-Infected Patients Comparing Tenofovir Disoproxil Fumarate Administered in Combination With Lamivudine and Efavirenz vs. Stavudine, Lamivudine and Efavirenz.(Extension) |
| Lead sponsor | Gilead Sciences, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Viread (tenofovir disoproxil fumarate), Sustiva (Efavirenz), Epivir (Lamivudine), Zerit (Stavudine) Placebo |
| Enrollment | 180 |
| Start date | Mar 1, 2000 |
| Primary completion | Dec 1, 2001 |
| Completion | Jun 1, 2013 |
| First posted | Sep 12, 2005 |
| Last update posted | Jun 25, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: